HCA · 8-K · 20261027PR432665

Guidance / Outlook

HCA Healthcare, Inc. · 2026-10-27 · Importance 62 · Surprise 42 · In source text

HCA said on October 27, 2026, that it expects full-year 2026 operating results in the upper half of the guidance ranges issued July 14, 2026. The published ranges are revenue of $77.0 billion to $79.5 billion, net income attributable to HCA of $6.3 billion to $6.7 billion, and Adjusted EBITDA of $15.4 billion to $16.1 billion. Guidance assumptions include volume growth, a mostly stable operating environment, payer mix, health care policy developments—including exchange reforms and expiration of enhanced premium tax credits—and inflation and trade policies, including tariffs.

Key facts

• HCA's 2026 guidance forecast revenue of $77.0 billion to $79.5 billion for the year ending December 31, 2026. source
• HCA's 2026 guidance forecast net income attributable to HCA Healthcare, Inc. of $6.3 billion to $6.7 billion. source
• HCA's 2026 guidance forecast Adjusted EBITDA of $15.4 billion to $16.1 billion. source
• HCA's 2026 guidance forecast diluted earnings per share of $28.70 to $30.50. source
• HCA's full-year 2026 operating results are now expected to be in the upper half of the guidance ranges previously issued July 14, 2026. source
• HCA's guidance excludes the impact of future approvals that could affect reimbursement under certain state Medicaid directed and supplemental payments. source
• The expiration of enhanced premium tax credits at the end of 2025 is identified as a potential factor affecting HCA's business and health insurance exchange coverage. source
• HCA identifies potential reductions or changes in Medicare, Medicaid and other state programs, including supplemental payment programs, as risks that may negatively affect provider reimbursement. source

Impact estimates